Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus

Christine E. Henry(University of North Carolina at Chapel Hill), Yingying Wang(Johns Hopkins University), Qi Yang(University of North Carolina at Chapel Hill), Thuy Hoang(Johns Hopkins Medicine), Sumon Chattopadhyay(Johns Hopkins University), Timothy E. Hoen(Johns Hopkins University), Laura M. Ensign(Johns Hopkins University), Kenetta L. Nunn(University of North Carolina at Chapel Hill), Holly A. Schroeder(University of North Carolina at Chapel Hill), Justin McCallen(University of North Carolina at Chapel Hill), Thomas R. Moench(ReProtect (United States)), Richard A. Cone(Johns Hopkins University), Steve R. Roffler(Institute of Biomedical Sciences, Academia Sinica), Samuel K. Lai(UNC/NCSU Joint Department of Biomedical Engineering)
Acta Biomaterialia
July 16, 2016
10.1016/j.actbio.2016.07.019
Cited by 61

Abstract

Related Papers

Effect of pegylation on pharmaceuticals
J. Milton Harris, Robert B. Chess|Nature Reviews Drug Discovery|2003|3.4k
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Alexander L. Klibanov, Kazuo Maruyama, Vladimir P. Torchilin et al.|FEBS Letters|1990|2k
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Samuel K. Lai, Yingying Wang, Justin Hanes|Advanced Drug Delivery Reviews|2008|1.7k
Handbook of Mucosal Immunology
|Elsevier eBooks|1994|707
Anti‐<scp>PEG</scp>immunity: emergence, characteristics, and unaddressed questions
Qi Yang, Samuel K. Lai|Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology|2015|573